NCT02111863 Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma Status TERMINATED Phase PHASE2
NCT02036476 Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Status TERMINATED Phase PHASE2
NCT02032810 Phase I of Histone Deacetylase (HDAC) Inhibitor Panobinostat With Ipilimumab With Unresectable III/IV Melanoma Status COMPLETED Phase PHASE1
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A
NCT01835626 Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma Status COMPLETED Phase PHASE2
NCT01820234 Evaluation of Store-and-Forward Teledermatology Versus a Face-to-Face Assessment During a Skin Cancer Screening Event Status COMPLETED Phase NA
NCT01508013 An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk Status COMPLETED Phase NA
NCT01495572 Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor Cells Status TERMINATED Phase PHASE2
NCT01468818 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma Status TERMINATED Phase PHASE2
NCT01458002 Online Tailored Interventions & Relational Agents for Exercise and Sun Protection Status COMPLETED Phase NA
NCT01447355 Vitamin D Levels in the Skin of Healthy Subjects After Oral Supplementation Status COMPLETED Phase PHASE1
NCT01447199 The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) Status UNKNOWN Phase N/A
NCT01385943 VivaNet Study. A Multicenter Study of Confocal Reflectance Microscopy in Telemedicine Status WITHDRAWN Phase N/A
NCT01369888 Use of IL-15 After Chemotherapy and Lymphocyte Transfer in Metastatic Melanoma Status TERMINATED Phase PHASE1/PHASE2